Advocating for Patients

AAFA Brings Patient Voice to FDA Committee Review on Palforzia, Oral Immunotherapy Treatment for Peanut Allergy

On Sept. 13, 2019, the U.S. Food and Drug Administration’s (FDA) Allergenic Products Advisory Committee recommended the approval of Aimmune Therapeutics’ peanut treatment, Palforzia. If approved, Palforzia would be ground-breaking for the future of food allergy treatments. What Is Palforzia? Palforzia, also known as AR101, is a type of oral immunotherapy (OIT) for peanut allergy. If approved, it would be the first FDA-approved treatment for peanut allergy. Currently, some allergists already...

2019 State Honor Roll: Does Your State Have Policies to Protect Children With Food Allergies and Asthma?

States that have policies in place to protect children with allergies and asthma made our 2019 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR). In the SHR, the Asthma and Allergy Foundation of America (AAFA) identifies states that have comprehensive laws and policies aimed at keeping children with asthma and allergies healthy at school. (KFA is a division of AAFA.)

Facebook Live: New Food Allergy Treatments

Join Dr. Katie Freidman of Forever Freckled and Kenny Mendez, President and CEO of the Asthma and Allergy Foundation of America (AAFA) and Kids With Food Allergies, a division of AAFA, for a Facebook Live discussion around what parents need to know about new treatments for kids with food allergies, in particular, peanut allergy. Thursday, July 25, 2019, at 1:30 – 2 pm ET.

New York Residents: Ask New York Governor Cuomo to Sign Elijah’s Law

Elijah’s Law, A6971B, is a bill recently passed by the New York State Assembly and Senate aimed at preventing another tragedy like Elijah's. It is now waiting to be signed by Governor Andrew Cuomo. The bill would require anaphylaxis policies for child day care centers. New York State residents can use this tool to tell New York's governor to support Elijah’s Law.

Asthma and Allergy Foundation of America Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).

Understanding What J.D. v. Williamsburg Means for People With Food Allergies

On May 31, 2019, the U.S. Court of Appeals of the Fourth Circuit ruled on a case important to the food allergy community – J.D. v. Williamsburg. J.D.'s family sued Colonial Williamsburg, saying they discriminated against someone with a disability when they didn’t let him eat his safe lunch in their restaurant while on a class trip. What does this mean for people with food allergies?

Court Ruling Favors People With Food Allergies, Gluten Sensitivity and Celiac Disease

J.D.'s family sued Colonial Williamsburg based on discrimination against someone with a disability. On May 31, 2019, the U.S. Court of Appeals of the Fourth Circuit ruled in favor of J.D. and his family. This ruling impacts people with food allergies, celiac disease and non-celiac gluten sensitivity. Allowing people to bring in safe food into a public place may be a necessary and reasonable accommodation. Food allergies are a disability under that Americans With Disabilities Act (ADA).

Spread Food Allergy Awareness in One Click

May is National Asthma and Allergy Awareness Month, and Food Allergy Awareness Week May 12-18. All through May, our focus is on raising awareness about how food allergies are more than just a physical condition and they impact every aspect of life. Help us raise awareness about food allergies by changing your social media profile pictures and tweet food allergy facts.

Post
Kids With Food Allergies
A Division of the Asthma and Allergy Foundation of America
1235 South Clark Street Suite 305, Arlington, VA 22202
Phone: 1-800-7-ASTHMA (1.800.727.8462)
-->
×
×
×
×